Report cover image

Dermatologicals in Slovakia

Published Oct 03, 2025
Length 23 Pages
SKU # EP20463689

Description

Dermatologicals continues to post solid single-digit retail value growth in 2025. Demand is supported by strong sales of topical antifungals and other dermatologicals, with consumers increasingly turning to products for issues such as hair loss, dandruff, acne and dermatitis. Price increases are also contributing to retail value growth, although they are limiting volume growth in certain segments.

Euromonitor International's Dermatologicals in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

23 Pages
Dermatologicals in Slovakia
Euromonitor International
October 2025
List Of Contents And Tables
DERMATOLOGICALS IN SLOVAKIA
KEY DATA FINDINGS
2025 DEVELOPMENTS
Rising demand driven by antifungals and other treatments
Bayer leads with Bepanthen and Canesten
Pharmacies dominates distribution, but e-commerce expands rapidly
PROSPECTS AND OPPORTUNITIES
Steady growth outlook for forecast period
AI tools supporting category expansion
Growth potential with some constraints
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2020-2025
Table 2 Sales of Dermatologicals by Category: % Value Growth 2020-2025
Table 3 NBO Company Shares of Dermatologicals: % Value 2021-2025
Table 4 LBN Brand Shares of Dermatologicals: % Value 2022-2025
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2022-2025
Table 6 Forecast Sales of Dermatologicals by Category: Value 2025-2030
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2025-2030
CONSUMER HEALTH IN SLOVAKIA
EXECUTIVE SUMMARY
Consumer health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2020-2025
Table 9 Life Expectancy at Birth 2020-2025
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2020-2025
Table 11 Sales of Consumer Health by Category: % Value Growth 2020-2025
Table 12 NBO Company Shares of Consumer Health: % Value 2021-2025
Table 13 LBN Brand Shares of Consumer Health: % Value 2022-2025
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2020-2025
Table 15 Distribution of Consumer Health by Format: % Value 2020-2025
Table 16 Distribution of Consumer Health by Format and Category: % Value 2025
Table 17 Forecast Sales of Consumer Health by Category: Value 2025-2030
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2024-2025
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.